A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors
新型 MDM2/p53 抑制剂阿利佐马德林在晚期实体肿瘤中的首次人体 I 期研究
期刊:ESMO Open
影响因子:7.1
doi:10.1016/j.esmoop.2024.103636
X Zhang, X Wen, R Peng, Q Pan, D Weng, Y Ma, Y Zhang, J Yang, L Men, H Wang, E Liang, C Wang, D Yang, L Zhang, Y Zhai